Vivimed Labs posts Q4FY22 consolidated loss at Rs. 18.33 Cr

The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022

Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr

Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore

Thyrocare opens regional processing lab in Ahmedabad

New Regional Processing Lab will serve Ahmedabad and the state of Gujarat

Merck’s pembrolizumab demonstrates improvement in distant metastasis

Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).

C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India

C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India

Israeli researchers create sperm on a chip

A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030

Innate Pharma announces IPH5201 phase 2 study in lung cancer

Innate to receive $5M milestone payment from AstraZeneca

RH Capital announces investments to improve women’s health

RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.

LEO Pharma strengthens its commercial organization

The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally

CMP Pharma announces calcium channel blocker ‘Norliqva’ availability

Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.

Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

How would AI change manufacturing & packaging processes?

These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022

Ovensa and Celanese to collaborate to advance precision drug delivery

Vial to launch oncology CRO, Arati Rao named as First Advisor

The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.

Proexp Pharma collaborates with Carbanio

As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company